Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Re-EMBARC
NCT05892744Phase 4Recruiting
- Sponsor
- University of Texas at Austin
- Start
- Sep 2023
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sertraline in major depressive disorder (MDD), sponsored by University of Texas at Austin. Started Sep 2023; status: recruiting.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05892744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05892744.